Tempus AI, Inc. Class A Common Stock

Day range

$64.03 – $68.02

Open

$67.61

Prev close

$67.62

Volume

3.75M

Market cap

$12.32B

Shares out

175.39M

P/E

—

P/S

8.61

P/B

27.70

P/FCF

—

ROE

-57.2%

ROA

-10.8%

Debt/Equity

3.06

Div yield

0.00%

As of Oct 23, 2026

• Licensing agreementOct 23, 2026

  On October 22, 2026, Tempus and Pathos entered into the Neuro Order Form ... Pursuant to the Neuro Order Form, Tempus will use commercially reasonable efforts to deliver and license to Pathos 500,000 de-identified records of patients diagnosed with Alzheimer's disease or other specified neurological conditions ... Tempus has also granted Pathos a license to an agentic tool that permits interrogation and analysis of the licensed data.

• Merger agreementJul 20, 2026

  On July 20, 2026, Tempus AI, Inc., a Nevada corporation ('Tempus'), entered into an Agreement and Plan of Merger (the 'Merger Agreement') by and among Tempus, Personalis, Inc., a Delaware corporation ('Personalis'), Aviary Development, Inc., a Delaware corporation and a wholly-owned subsidiary of Tempus ('Merger Sub I') and Toucan Development, LLC, a Nevada limited liability company and a wholly-owned subsidiary of Tempus ('Merger Sub II'). Pursuant to the Merger Agreement, and upon the terms and subject to the conditions therein, (a) Merger Sub I will be merged with and into Personalis (the 'First Merger'), with Personalis surviving the First Merger as a wholly-owned subsidiary of Tempus (the 'First Surviving Corporation'), and (b) as part of the same overall transaction, immediately after the First Merger, the First Surviving Corporation will merge with and into Merger Sub II (the 'Second Merger' and, together with the First Merger, the 'Mergers'), with Merger Sub II surviving as a wholly-owned subsidiary of Tempus (the 'Surviving Company').

• Merger agreementJul 20, 2026

  Tempus AI, Inc., a Nevada corporation ('Tempus'), and Personalis, Inc., a Delaware corporation ('Personalis'), announced that they had entered into an Agreement and Plan of Merger (the 'Merger Agreement'), by and among Tempus, Aviary Development, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Tempus ('Merger Sub I'), Toucan Development, LLC, a Nevada limited liability company and a direct, wholly-owned subsidiary of Tempus ('Merger Sub II'), and Personalis, pursuant to which, subject to the terms and conditions of the Merger Agreement, (i) Merger Sub I will merge with and into Personalis (the 'First Merger'), with Personalis surviving the First Merger as a direct, wholly-owned subsidiary of Tempus, and (ii) immediately following the First Merger, Personalis will merge with and into Merger Sub II (the 'Second Merger'), with Merger Sub II surviving the Second Merger as a direct, wholly-owned subsidiary of Tempus.

• Debt issuanceMay 13, 2026

  On May 12, 2026, Tempus AI, Inc. (the "Company") completed its previously announced private offering (the "Offering") of $460.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the "Notes")... The Notes were issued pursuant to an indenture, dated May 12, 2026 (the "Indenture"), between the Company and U.S. Bank Trust Company, National Association, as trustee.

• Preliminary resultsJan 12, 2026

  On January 11, 2026, Tempus AI, Inc. (the "Company") issued a press release regarding its preliminary financial results for the quarter ended and full year ended December 31, 2025.

Days to cover

3.2

Short interest

25.12M

Avg volume

7.79M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Tempus AI (TEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
  positiveZacks Investment Research· Oct 26, 2026
• Natera Partners With TransCode to Advance Colorectal Cancer Trial
  positiveZacks Investment Research· Oct 21, 2026
• Here's How Tempus AI Demonstrates Improving Operating Leverage
  positiveZacks Investment Research· Oct 19, 2026
• Tempus AI Expands Strategic Collaborations to Drive Future Growth
  neutralZacks Investment Research· Oct 12, 2026
• Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
  neutralZacks Investment Research· Oct 9, 2026